In the former category, gene disruption through recurrent deletion was only described for TENM3 in gliomas (Glover et al., 2017), and homozygous loss of TENM3 was also found in an embryonal rhabdomyosarcoma associated with high risk clinical parameters (Walther et al., 2016). Here, TENM3 is linked to central nervous system cancer.